Samantha M. Ebeyan
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: evaluation of a multiplex real-time PCR assay.
Journal: Journal of medical microbiology
Published: February 22, 2021
Evaluation of the SpeeDx MG parC (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations.
Journal: Journal of clinical microbiology
Published: July 29, 2020
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
Journal: The Journal of antimicrobial chemotherapy
Published: February 25, 2020
Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations.
Journal: Journal of clinical microbiology
Published: January 04, 2020
Evaluation of the ResistancePlus MG FleXible Assay for Detection of Wild-Type and 23S rRNA-Mutated Mycoplasma genitalium Strains.
Journal: Journal of clinical microbiology
Published: November 13, 2019
Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
Journal: Journal of clinical microbiology
Published: June 04, 2019
Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
Journal: The Journal of antimicrobial chemotherapy
Published: March 07, 2019
Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
Journal: The Journal of antimicrobial chemotherapy
Published: October 21, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026